These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28158880)

  • 21. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.
    Nogami N; Takigawa N; Hotta K; Segawa Y; Kato Y; Kozuki T; Oze I; Kishino D; Aoe K; Ueoka H; Kuyama S; Harita S; Okada T; Hosokawa S; Inoue K; Gemba K; Shibayama T; Tabata M; Takemoto M; Kanazawa S; Tanimoto M; Kiura K
    Lung Cancer; 2015 Feb; 87(2):141-7. PubMed ID: 25534129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer.
    Martin J; Ginsberg RJ; Venkatraman ES; Bains MS; Downey RJ; Korst RJ; Kris MG; Rusch VW
    J Clin Oncol; 2002 Apr; 20(8):1989-95. PubMed ID: 11956257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of adjuvant chemotherapy in patient with early stages of non-small cell lung cancer depending on proliferation index of tumor].
    Kolesnik AP
    Lik Sprava; 2014; (1-2):110-7. PubMed ID: 24908971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
    Kim AW; Liptay MJ; Bonomi P; Warren WH; Basu S; Farlow EC; Faber LP
    Ann Thorac Surg; 2011 Jul; 92(1):233-41; discussion 241-3. PubMed ID: 21620372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.
    Nicoli CD; Sprague BL; Anker CJ; Lester-Coll NH
    Am J Clin Oncol; 2019 Jul; 42(7):607-614. PubMed ID: 31232724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy.
    Jørgensen N; Meline EL; Jeppesen SS; Hansen O; Nielsen M; Schytte T
    Acta Oncol; 2019 Oct; 58(10):1393-1398. PubMed ID: 31271075
    [No Abstract]   [Full Text] [Related]  

  • 28. Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival.
    David EA; Canter RJ; Chen Y; Cooke DT; Cress RD
    Ann Thorac Surg; 2016 Oct; 102(4):1101-9. PubMed ID: 27293147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in older patients with advanced non-small cell lung cancer in China.
    Su Q; Sun YP; Liu YH; Li Z; Yang HY; Sun ZG; Cao BW; Jia JH
    Tumori; 2014; 100(1):69-74. PubMed ID: 24675494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
    Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
    Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
    Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
    Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of local therapy for stage I non-small-cell lung cancer in nonagenarians.
    Arnold BN; Thomas DC; Rosen JE; Salazar MC; Detterbeck FC; Blasberg JD; Boffa DJ; Kim AW
    Surgery; 2017 Sep; 162(3):640-651. PubMed ID: 28697883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
    J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.